Micreos is a platform biotech company focused on discovering and developing recombinant antimicrobial enzymes for chronic dermatological disease

Micreos is a pre clinical stage pharmaceutical biotech developing enzymes that selectively kill only harmful bacteria while preserving the rest of the microbiome.

Our vision is to positively impact patient care while helping global health care systems to address dermatological conditions with high unmet medical need

Our unique capability to optimise enzyme therapeutics means that we have already developed an endolysin based investigational enzyme.

These antimicrobials are focused on the detrimental impact of Staphylococcus sp. In dermatology.

Our team is forging ahead, partnering across medicine, to realise the shared goal of better solutions to combat harmful bacteria in chronic disease.

Micreos

Org chart

Teams

Offices